Annovis Bio, Inc. · NYSE:ANVS
Empery Asset Management, LP's stake in Annovis Bio, Inc. fell to 4.99% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Oct 15, 2026
Empery Asset Management, LP's stake in Annovis Bio, Inc. fell to 4.99%, 2,241,537 shares, as a passive investor on Sep 30, 2026. Filed Oct 15, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 2,241,537
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 4.99% | 2,241,537 |
| Ryan M. Lane | 4.99% | 2,241,537 |
Source
Download original · View original at SEC
Related
- Annovis Bio, Inc.
- Empery Asset Management, LP
- Annovis Bio, Inc. shareholders
- Schedule 13G · Empery Asset Management, LP · Jul 29, 2026
- Schedule 13G · Highbridge Capital Management LLC · Aug 14, 2026
- Form 4 · Hoffman Michael B · May 21, 2026
- Form 4 · Hoffman Michael B · Apr 3, 2026
- Schedule 13G/A · CVI Investments, Inc. · May 12, 2025
- Schedule 13G · CVI Investments, Inc. · Feb 10, 2025